Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,019 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to commentary by Miller.
Kobashi Y, Hasegawa A, Yamashita S. Kobashi Y, et al. Among authors: hasegawa a. Health Phys. 2024 Dec 1;127(6):726. doi: 10.1097/HP.0000000000001879. Health Phys. 2024. PMID: 39432861 No abstract available.
Spatial proteomics identifies JAKi as treatment for a lethal skin disease.
Nordmann TM, Anderton H, Hasegawa A, Schweizer L, Zhang P, Stadler PC, Sinha A, Metousis A, Rosenberger FA, Zwiebel M, Satoh TK, Anzengruber F, Strauss MT, Tanzer MC, Saito Y, Gong T, Thielert M, Kimura H, Silke N, Rodriguez EH, Restivo G, Nguyen HH, Gross A, Feldmeyer L, Joerg L, Levesque MP, Murray PJ, Ingen-Housz-Oro S, Mund A, Abe R, Silke J, Ji C, French LE, Mann M. Nordmann TM, et al. Among authors: hasegawa a. Nature. 2024 Oct 16. doi: 10.1038/s41586-024-08061-0. Online ahead of print. Nature. 2024. PMID: 39415009
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.
Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, Shimizu T, Kawakami A, Tanaka K, Tsuji T, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, Nakajima H; Japan VEXAS study group. Kirino Y, et al. Among authors: hasegawa a. Rheumatology (Oxford). 2024 Sep 28:keae530. doi: 10.1093/rheumatology/keae530. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39340799
A case of Darier's disease with a missense mutation in exon 8 of ATP2A2.
Hasegawa A, Matsuda KM, Ogishi M, Miura S, Yoshizaki A, Chaldebas M, Milisavljevic B, Zhang P, Casanova JL, Sato S. Hasegawa A, et al. J Dermatol. 2024 Sep 24. doi: 10.1111/1346-8138.17477. Online ahead of print. J Dermatol. 2024. PMID: 39315574 No abstract available.
Advancements in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: Utilizing Fas-FasL Inhibition to Target Cell Death Signaling Pathways for Practical Human Application.
Saito Y, Lotti R, Kimura H, Hasegawa A, Bennett B, Amato A, Pincelli C, Abe R. Saito Y, et al. Among authors: hasegawa a. J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02106-7. doi: 10.1016/j.jid.2024.08.028. Online ahead of print. J Invest Dermatol. 2024. PMID: 39303908 No abstract available.
2,019 results